Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 28/54
Mike
DeWine
U.S. Senate · R-OH
Taken from pharma & insurers
$31,072
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 28/54
Pharma & Health$23,222
Insurers & HMOs$7,850
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 28 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$31,072
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
After office
We checked the public record. No industry job, board seat, or gift after this vote.
Sometimes the vote really is free.
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$23,222
Johnson & Johnson$13,922
Amgen$7,500
Merck$1,000
Bristol Myers Squibb$500
Pfizer$300
Insurers & HMOs$7,850
Cigna$3,000
Aetna$2,750
Humana$2,100